Emma is an Associate Professor in Law with a research specialism in applied public inquiry law and procedure. Her work focuses on improving understanding of the role and function of public inquiries ...

Also, how might tariffs impact GSK, and what are the mitigating strategies? A: (Dame Emma Walmsley, CEO) We are excited about the new launches. For Nucala COPD, the May 7th PDUFA is on track ...

GSK said it remains confident in its ability to absorb the financial impact of potential US pharmaceutical tariffs as it posted a 4% rise in Q1 2025 sales to £7.52bn ($10.05bn), driven by growth ...

CEO Emma Walmsley said GSK is starting “from a position of strength” and is considering accelerating the use of AI to support productivity and mitigate cost base increases: “Technology is advancing ...

The pharma giant’s chief executive Emma Walmsley said European nations faced ‘tough choices’ on investment’. But she ‘absolutely agreed’ that backing the creation of new drugs and ...

This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of ...

GSK chief executive Emma Walmsley said the business is making ‘strong progress’ (GSK/PA) “The company is well positioned to respond to the potential financial impact of sector-specific tariffs, should ...

Drugmaker GSK (GlaxoSmithKline) has said it is “well positioned” to cope with any financial impact from changes to US tariff rules. It came as the FTSE 100 giant revealed a rise in sales as ...